Alaunos Therapeutics, Inc. Common Stock

TCRTNASDAQUSD
2.73 USD
0.00 (0.00%)🟢PRE MARKET (AS OF 07:54 PM EDT)
🟢Market: OPEN
Open?$2.75
High?$2.85
Low?$2.68
Prev. Close?$2.70
Volume?10.0K
Avg. Volume?16.4K
VWAP?$2.72
Rel. Volume?0.61x
Bid / Ask
Bid?$2.33 × 100
Ask?$3.16 × 100
Spread?$0.83
Midpoint?$2.75
Valuation & Ratios
Market Cap?6.4M
Shares Out?2.4M
Float?1.9M
Float %?82.3%
P/E Ratio?N/A
P/B Ratio?2.98
EPS?-$1.80
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.45Strong
Quick Ratio?2.45Strong
Cash Ratio?1.70Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
2.98CHEAP
P/S?
1,284.26HIGH
P/FCF?
N/A
EV/EBITDA?
-1.2CHEAP
EV/Sales?
1,007.26HIGH
Returns & Efficiency
ROE?
-198.9%WEAK
ROA?
-144.4%WEAK
Cash Flow & Enterprise
FCF?$-2967000
Enterprise Value?$5.0M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
Employees
1
Market Cap
6.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2005-08-24
Address
501 E LAS OLAS BLVD
FORT LAUDERDALE, FL 33301
Phone: (346) 355-4099